{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T04:00:44Z","timestamp":1792728044698,"version":"4.5.0"},"reference-count":51,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,5,3]],"date-time":"2020-05-03T00:00:00Z","timestamp":1588464000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002367","name":"Chinese Academy of Sciences","doi-asserted-by":"publisher","award":["XDA12050307"],"award-info":[{"award-number":["XDA12050307"]}],"id":[{"id":"10.13039\/501100002367","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013076","name":"National Major Science and Technology Projects of China","doi-asserted-by":"publisher","award":["2018ZX09721002\u2013009"],"award-info":[{"award-number":["2018ZX09721002\u2013009"]}],"id":[{"id":"10.13039\/501100013076","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Pharmaceutica Sinica B"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.apsb.2020.04.015","type":"journal-article","created":{"date-parts":[[2020,5,7]],"date-time":"2020-05-07T12:05:58Z","timestamp":1588853158000},"page":"1709-1718","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"title":["Glycoside scutellarin enhanced CD-MOF anchoring for laryngeal delivery"],"prefix":"10.1016","volume":"10","author":[{"given":"Kena","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caifen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priyanka","family":"Mittal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Senlin","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruxandra","family":"Gref","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiwen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.apsb.2020.04.015_bib1","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.ejrad.2008.03.027","article-title":"Imaging of the larynx and hypopharynx","volume":"66","author":"Becker","year":"2008","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.apsb.2020.04.015_bib2","doi-asserted-by":"crossref","first-page":"74","DOI":"10.17116\/patol20198105174","article-title":"Tumor-like amyloidosis of the upper respiratory tract","volume":"81","author":"Bykova","year":"2019","journal-title":"Arkh Patol"},{"key":"10.1016\/j.apsb.2020.04.015_bib3","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.compbiomed.2015.02.001","article-title":"Classification of laryngeal disorders based on shape and vascular defects of vocal folds","volume":"62","author":"Irem Turkmen","year":"2015","journal-title":"Comput Biol Med"},{"key":"10.1016\/j.apsb.2020.04.015_bib4","first-page":"758","article-title":"Disorders of the larynx and chronic inflammatory diseases","volume":"91","author":"Pickhard","year":"2012","journal-title":"Laryngo-Rhino-Otol"},{"key":"10.1016\/j.apsb.2020.04.015_bib5","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1002\/lary.21796","article-title":"The use of lipid microtubes as a novel slow-release delivery system for laryngeal injection","volume":"121","author":"Kolachala","year":"2011","journal-title":"Laryngoscope"},{"key":"10.1016\/j.apsb.2020.04.015_bib6","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1023\/A:1011964813817","article-title":"Ultrasonic nebulization of cationic lipid-based gene delivery systems for airway administration","volume":"15","author":"Pillai","year":"1998","journal-title":"Pharm Res"},{"key":"10.1016\/j.apsb.2020.04.015_bib7","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1002\/lary.20856","article-title":"Slow-release nanoparticle-encapsulated delivery system for laryngeal injection","volume":"120","author":"Kolachala","year":"2010","journal-title":"Laryngoscope"},{"key":"10.1016\/j.apsb.2020.04.015_bib8","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1080\/10826068.2019.1599395","article-title":"Preparation and characterization of novel albumin-sericin nanoparticles as siRNA delivery vehicle for laryngeal cancer treatment","volume":"49","author":"Yalcin","year":"2019","journal-title":"Prep Biochem Biotechnol"},{"key":"10.1016\/j.apsb.2020.04.015_bib9","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1111\/j.1742-1241.2008.01984.x","article-title":"Scintigraphy can be used to compare delivery of sore throat formulations","volume":"63","author":"Limb","year":"2009","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.apsb.2020.04.015_bib10","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1111\/j.1742-1241.2009.02230.x","article-title":"Rapid relief of acute sore throat with AMC\/DCBA throat lozenges: randomised controlled trial","volume":"64","author":"McNally","year":"2010","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.apsb.2020.04.015_bib11","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1002\/(SICI)1097-4636(19970615)35:4<525::AID-JBM12>3.0.CO;2-A","article-title":"Inhibition of smooth muscle cell growth in\u00a0vitro by an antisense oligodeoxynucleotide released from poly (d,l-lactic-co-glycolic acid) microparticles","volume":"35","author":"Cleek","year":"1997","journal-title":"J Biomed Mater Res"},{"key":"10.1016\/j.apsb.2020.04.015_bib12","first-page":"26","article-title":"Sprays and lozenges for sore throats","volume":"78","author":"Farrer","year":"2011","journal-title":"S Afr Pharm Pract"},{"key":"10.1016\/j.apsb.2020.04.015_bib13","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.apsb.2016.03.011","article-title":"Influence of physical properties of carrier on the performance of dry powder inhalers","volume":"6","author":"Peng","year":"2016","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2020.04.015_bib14","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.apsb.2018.03.004","article-title":"Inhalation treatment of primary lung cancer using liposomal curcumin dry powder inhalers","volume":"8","author":"Zhang","year":"2018","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2020.04.015_bib15","first-page":"1","article-title":"Comparison of aerodynamic particle size distribution between a next generation impactor and a cascade Impactor at a range of flow rates","volume":"18","author":"Yoshida","year":"2016","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.apsb.2020.04.015_bib16","doi-asserted-by":"crossref","first-page":"5270","DOI":"10.1002\/jps.22721","article-title":"Aerosol tribocharging and its relation to the deposition of Oxis\u2122 Turbuhaler\u00ae in the electrical next generation impactor","volume":"100","author":"Hoe","year":"2011","journal-title":"J Pharmaceut Sci"},{"key":"10.1016\/j.apsb.2020.04.015_bib17","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1023\/A:1012180924063","article-title":"Effect of drug load and plate coating on the particle size distribution of a commercial albuterol metered dose inhaler (MDI) determined using the Andersen and Marple-Miller cascade impactors","volume":"14","author":"Nasr","year":"1997","journal-title":"Pharm Res"},{"key":"10.1016\/j.apsb.2020.04.015_bib18","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1080\/10717544.2019.1618419","article-title":"In-vitro and in-vivo respiratory deposition of a developed metered dose inhaler formulation of an anti-migraine drug","volume":"26","author":"Abdou","year":"2019","journal-title":"Drug Deliv"},{"key":"10.1016\/j.apsb.2020.04.015_bib19","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1186\/s11671-015-1085-y","article-title":"Evaluation of high-performance curcumin nanocrystals for pulmonary drug delivery both in\u00a0vitro and in\u00a0vivo","volume":"10","author":"Hu","year":"2015","journal-title":"Nanoscale Res Lett"},{"key":"10.1016\/j.apsb.2020.04.015_bib20","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1208\/s12249-012-9797-0","article-title":"Effect of sampling volume on dry powder inhaler (DPI)-emitted aerosol aerodynamic particle size distributions (APSDs) measured by the Next-Generation Pharmaceutical Impactor (NGI) and the Andersen eight-stage cascade impactor (ACI)","volume":"13","author":"Mohammed","year":"2012","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.apsb.2020.04.015_bib21","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1177\/0194599817742126","article-title":"Ideal particle sizes for inhaled steroids targeting vocal granulomas: preliminary study using computational fluid dynamics","volume":"158","author":"Perkins","year":"2018","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.apsb.2020.04.015_bib22","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1089\/jam.2006.19.168","article-title":"A dry powder inhaler with reduced mouth-throat deposition","volume":"19","author":"Wang","year":"2006","journal-title":"J Aerosol Med"},{"key":"10.1016\/j.apsb.2020.04.015_bib23","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1002\/jps.20305","article-title":"SCF-engineered powders for delivery of budesonide from passive DPI devices","volume":"94","author":"Lobo","year":"2005","journal-title":"J Pharmaceut Sci"},{"key":"10.1016\/j.apsb.2020.04.015_bib24","doi-asserted-by":"crossref","first-page":"101229","DOI":"10.1016\/j.jddst.2019.101229","article-title":"Determination of emitted particle characteristics and upper airway deposition of Symbicort\u00ae Turbuhaler\u00ae dry powder inhaler","volume":"54","author":"Kugler","year":"2019","journal-title":"J Drug Deliv Sci Technol"},{"key":"10.1016\/j.apsb.2020.04.015_bib25","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.drudis.2013.11.013","article-title":"Alternative carriers in dry powder inhaler formulations","volume":"19","author":"Rahimpour","year":"2014","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.apsb.2020.04.015_bib26","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.ijpharm.2017.09.051","article-title":"Design of gefitinib-loaded poly (l-lactic acid) microspheres via a supercritical anti-solvent process for dry powder inhalation","volume":"532","author":"Lin","year":"2017","journal-title":"Int J Pharm"},{"key":"10.1016\/j.apsb.2020.04.015_bib27","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.addr.2014.04.005","article-title":"Dry powders for oral inhalation free of lactose carrier particles","volume":"75","author":"Healy","year":"2014","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.apsb.2020.04.015_bib28","doi-asserted-by":"crossref","first-page":"3986","DOI":"10.1002\/jps.22246","article-title":"Physical characterization of TRK-720 hydrate, the very late antigen-4 (VLA-4) inhibitor, as a solid form for inhalation: preparation of the hydrate by solvent exchange among its solvates and mechanistical considerations","volume":"99","author":"Shiraki","year":"2010","journal-title":"J Pharmaceut Sci"},{"key":"10.1016\/j.apsb.2020.04.015_bib29","doi-asserted-by":"crossref","first-page":"16730","DOI":"10.1002\/anie.201905724","article-title":"Revising complex supramolecular polymerization under kinetic and thermodynamic control. Supramolecular cyclodextrin-based hydrogels for controlled gene delivery","volume":"58","author":"Matern","year":"2019","journal-title":"Angew Chem Int Ed"},{"key":"10.1016\/j.apsb.2020.04.015_bib30","doi-asserted-by":"crossref","first-page":"5602","DOI":"10.1039\/C9TB01548E","article-title":"Recent progress in the synthesis, structural diversity and emerging applications of cyclodextrin-based metal-organic frameworks","volume":"7","author":"He","year":"2019","journal-title":"J Mater Chem B"},{"key":"10.1016\/j.apsb.2020.04.015_bib31","doi-asserted-by":"crossref","first-page":"8630","DOI":"10.1002\/anie.201002343","article-title":"Metal-organic frameworks from edible natural products","volume":"49","author":"Smaldone","year":"2010","journal-title":"Angew Chem"},{"key":"10.1016\/j.apsb.2020.04.015_bib32","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.ejpb.2018.02.009","article-title":"Supramolecular cyclodextrin-based metal-organic frameworks as efficient carrier for anti-inflammatory drugs","volume":"127","author":"Abu\u00e7afy","year":"2018","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.apsb.2020.04.015_bib33","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s11095-019-2650-3","article-title":"MOF Capacitates cyclodextrin to mega-load mode for high-efficient delivery of valsartan","volume":"36","author":"Zhang","year":"2019","journal-title":"Pharm Res"},{"key":"10.1016\/j.apsb.2020.04.015_bib34","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ijpharm.2018.11.074","article-title":"A \u201cShip-in-a-Bottle\u201d strategy to create folic acid nanoclusters inside the nanocages of \u03b3-cyclodextrin metal-organic frameworks","volume":"556","author":"Xu","year":"2019","journal-title":"Int J Pharm"},{"key":"10.1016\/j.apsb.2020.04.015_bib35","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s11095-016-2059-1","article-title":"Improvement in thermal stability of sucralose by \u03b3-cyclodextrin metal-organic frameworks","volume":"34","author":"Lv","year":"2019","journal-title":"Pharm Res"},{"key":"10.1016\/j.apsb.2020.04.015_bib36","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.carbpol.2019.04.037","article-title":"\u03b3-Cyclodextrin-metal organic frameworks as efficient microcontainers for encapsulation of leflunomide and acceleration of its transformation into teriflunomide","volume":"216","author":"Kritskiy","year":"2019","journal-title":"Carbohydr Polym"},{"key":"10.1016\/j.apsb.2020.04.015_bib37","doi-asserted-by":"crossref","first-page":"9785","DOI":"10.1021\/acs.jafc.8b03144","article-title":"Novel approach with controlled nucleation and growth for green synthesis of size-controlled cyclodextrin-based metal-organic frameworks based on short-chain starch nanoparticles","volume":"66","author":"Chao","year":"2018","journal-title":"J Agric Food Chem"},{"key":"10.1016\/j.apsb.2020.04.015_bib38","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1021\/acs.molpharmaceut.7b00168","article-title":"Encapsulation of Ibuprofen in CD-MOF and related bioavailability studies","volume":"14","author":"Hartlieb","year":"2017","journal-title":"Mol Pharm"},{"key":"10.1016\/j.apsb.2020.04.015_bib39","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.ijpharm.2017.05.056","article-title":"Cyclodextrin-based metal-organic frameworks particles as efficient carriers for lansoprazole: study of morphology and chemical composition of individual particles","volume":"531","author":"Li","year":"2017","journal-title":"Int J Pharm"},{"key":"10.1016\/j.apsb.2020.04.015_bib40","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.foodchem.2016.06.013","article-title":"Encapsulation of curcumin in cyclodextrin-metal organic frameworks: dissociation of loaded CD-MOFs enhances stability of curcumin","volume":"212","author":"Moussa","year":"2016","journal-title":"Food Chem"},{"key":"10.1016\/j.apsb.2020.04.015_bib41","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1080\/02652048.2018.1462417","article-title":"Enhanced stability of vitamin A palmitate microencapsulated by \u03b3-cyclodextrin metal-organic frameworks","volume":"35","author":"Zhang","year":"2018","journal-title":"J Microencapsul"},{"key":"10.1016\/j.apsb.2020.04.015_bib42","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.ijpharm.2019.04.030","article-title":"Nanoporous CD-MOF particles with uniform and inhalable size for pulmonary delivery of budesonide","volume":"564","author":"Hu","year":"2019","journal-title":"Int J Pharm"},{"key":"10.1016\/j.apsb.2020.04.015_bib43","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.ijpharm.2016.09.029","article-title":"Optimized synthesis and crystalline stability of \u03b3-cyclodextrin metal-organic frameworks for drug adsorption","volume":"514","author":"Liu","year":"2016","journal-title":"Int J Pharm"},{"key":"10.1016\/j.apsb.2020.04.015_bib44","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1021\/ja208224f","article-title":"Nanoporous carbohydrate metal\u2013organic frameworks","volume":"134","author":"Forgan","year":"2011","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.apsb.2020.04.015_bib45","doi-asserted-by":"crossref","first-page":"480","DOI":"10.3109\/10717544.2014.883113","article-title":"Effects of formulation and operating variables on Zanamivir dry powder inhalation characteristics and aerosolization performance","volume":"21","author":"Yang","year":"2014","journal-title":"Drug Deliv"},{"key":"10.1016\/j.apsb.2020.04.015_bib46","first-page":"1","article-title":"Development of dry powder inhaler formulation loaded with alendronate solid lipid nanoparticles: solid-state characterization and aerosol dispersion performance","volume":"41","author":"Ezzati Nazhad Dolatabadi","year":"2014","journal-title":"Drug Dev Ind Pharm"},{"key":"10.1016\/j.apsb.2020.04.015_bib47","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1089\/jamp.2017.1379","article-title":"Dry-powder inhaler formulation of rifampicin: an improved targeted delivery system for alveolar tuberculosis","volume":"30","author":"Rawal","year":"2017","journal-title":"J Aerosol Med Pulm Drug Deliv"},{"key":"10.1016\/j.apsb.2020.04.015_bib48","first-page":"163","article-title":"Evaluating flow properties of solids","volume":"72","author":"Carr","year":"1965","journal-title":"Chem Eng"},{"key":"10.1016\/j.apsb.2020.04.015_bib49","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.ijpharm.2013.08.011","article-title":"The development of a sensitive methodology to characterise hard shell capsule puncture by dry powder inhaler pins","volume":"456","author":"Torrisi","year":"2013","journal-title":"Int J Pharm"},{"key":"10.1016\/j.apsb.2020.04.015_bib50","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1002\/ppul.24077","article-title":"Inspiromatic-safety and efficacy study of a new generation dry powder inhaler in asthmatic children","volume":"53","author":"Steuer","year":"2018","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.apsb.2020.04.015_bib51","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1016\/j.xphs.2018.05.018","article-title":"Preparation and quality evaluation of salvianolic acids and tanshinones dry powder inhalation","volume":"107","author":"Wang","year":"2018","journal-title":"J Pharm Sci-US"}],"container-title":["Acta Pharmaceutica Sinica B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383520305827?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383520305827?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T16:45:29Z","timestamp":1761929129000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211383520305827"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":51,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["S2211383520305827"],"URL":"https:\/\/doi.org\/10.1016\/j.apsb.2020.04.015","relation":{},"ISSN":["2211-3835"],"issn-type":[{"value":"2211-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Glycoside scutellarin enhanced CD-MOF anchoring for laryngeal delivery","name":"articletitle","label":"Article Title"},{"value":"Acta Pharmaceutica Sinica B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.apsb.2020.04.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences. Production and hosting by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}